
Market opportunities in nanomedicine
By Euromed
Leon-nanodrugs is starting the co-development business in nanomedicine, leading the way in supergenerics and high-barrier generics. Managing partner Dr Wolfgang Beier answers World Pharmaceutical Frontiers’ questions.
